Health
1 read
FDA Committee Approves Peptides for Compounding Despite Scientific Concerns

Want the full story?
Read the complete article at KTSM
AI Summary
A committee within the FDA has voted to allow compounding pharmacies to include peptides in their formulations, despite opposition from agency scientists who highlighted the absence of proven benefits. This decision, made on Thursday, marks a significant divergence from the scientific community's stance on the issue. The approval could impact how compounded medications are prepared and prescribed, raising questions about safety and efficacy for patients relying on these treatments. Residents should stay informed about potential changes in medication options and discuss with healthcare providers if they are considering compounded drugs.
health fda medications pharmaceuticals compounding
People & Organizations
FDA